Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa
HandiVIH
Disability and HIV: an Appraisal of the Vulnerability of People With Disabilities to HIV Infection in Two Main Cities of Sub-Saharan Africa
1 other identifier
observational
1,610
1 country
1
Brief Summary
According to the recent World Report on Disability, around 15% of the world population lives with a disability and 80% of people with disabilities (PWD) live in developing countries. More and more evidence show that PWD are more likely to be poor, vulnerable to physical and sexual violence, and to have less access to education. Therefore, PWD are likely to have an increased risk for HIV infection, potentially being a key population in regard to this epidemic. The vulnerability of PWD was recognized in 2007 by the United Nations Convention on the Rights of Persons with Disabilities. However, data on the extent how PWD are affected by HIV is still very limited. As a result, PWD are usually overlooked by National AIDS Control Programmes and few projects specifically targeting them have been developed. Recognizing the need for appropriate and reliable data to help protect the rights of PWD and achieve a better inclusion of disability in National AIDS Control Programmes, the Institute of Research for Development (IRD), the Institut de Formation et Recherche Demographique (IFORD) and Handicap International (HI) propose this study that aims to provide quantitative and qualitative data on the vulnerability of PWD to HIV infection in Cameroon and Burkina Faso, in order to define if this vulnerable population is also a Key Population in relation to the HIV epidemic. This study adopts a multidisciplinary approach (quantitative and qualitative methods). Quantitative data are collected only in Cameroon. Only the quantitative study is described here.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2014
CompletedFirst Posted
Study publicly available on registry
July 17, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedJuly 12, 2016
July 1, 2016
1.1 years
July 11, 2014
July 11, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
HIV prevalence
HIV prevalence among People With Disability compared to Non-Disabled People. HIV serology will be assessed by rapid diagnostic tests.
10 months
Secondary Outcomes (1)
Risk factors
10 months
Other Outcomes (1)
Access to care
10 months
Study Arms (2)
People with Disability (PWD) (N= 850)
PWD will be identified thanks to the disability screening tool developped by the Washington Group (WG). This tool is based on the WHO International Classification of Functionning (ICF). A stratified cluster sampling in 2 steps will be used in both, Yaounde and Ouagadougou. Each city will be divided in enumeration areas (EAs). First step : EAs will be drawn randomly with probability proportional to their size in number of households. Second step: in each EA, 30 households will be randomly drawn and each person living in these households will be screened for disability with the WG tool, according to the inclusion and exclusion criteria.
Non-Disabled People (control group) (N= 850)
For each PWD, 1 non-disabled control person will be randomly chosen from the census list of the same enumeration area. Control will also be matched on age and sex.
Eligibility Criteria
Community sample: \- PWD are identified thanks to the disability screening tool developped by the Washington Group (WG). This tool is based on the WHO International Classification of Functionning (ICF). A stratified cluster sampling in 2 steps is used in Yaounde. The city has been divided in enumeration areas (EAs). First step : EAs are drawn randomly with probability proportional to their size in number of households. Second step: in each EA, 30 households are randomly drawn and each person living in these households is screened for disability with the WG tool, according to the inclusion and exclusion criteria. \- For each PWD, 1 non-disabled control person is randomly chosen from the census list of the same enumeration area. Controls are matched on age and sex.
You may qualify if:
- Age 15 to 49 years
- WG criteria: ≥ 1 major impairment or 2 minor difficulties with an activity
- Informed consent given
You may not qualify if:
- Any severe disease that, according to the investigator, precludes the participation of the subject to ANY aspect of the study
- Temporary impairment (\>1 year) which is likely to be cured quickly
- Subject consenting to none of the aspects of the study.
- For Non-Disabled People (control group):
- Age 15 to 45 years in an interval of 5 years compared to the index PWD;
- Same sex as the index PWD;
- Not answering to the WG criteria for disability;
- Living in the same enumeration area as the Index PWD;
- Informed consent given.
- Any conditions, that - according to the interviewer - don't permit to participate at any part of the study;
- Subject consenting to none of the aspects of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ANRS, Emerging Infectious Diseaseslead
- Handicap Internationalcollaborator
- Institut de Recherche pour le Developpementcollaborator
- Institut de Formation et de Recherche Démographiquecollaborator
- Forum Camerounais de Psychologiecollaborator
- Centre de Recherche Internationale pour la Santé de l'Université de Ouagadougoucollaborator
Study Sites (1)
Unknown Facility
Yaoundé, Cameroon
Related Publications (1)
De Beaudrap P, Pasquier E, Tchoumkeu A, Touko A, Essomba F, Brus A, Desgrees du Lou A, Aderemi TJ, Hanass-Hancock J, Eide AH, Mont D, Mac-Seing M, Beninguisse G. HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations. BMJ Open. 2016 Feb 4;6(2):e008934. doi: 10.1136/bmjopen-2015-008934.
PMID: 26846895DERIVED
Study Officials
- STUDY DIRECTOR
Pierre DE BEAUDRAP, MD, PhD
Institut de Recherche pour le Developpement (IRD)
- STUDY DIRECTOR
Gervais BENINGISSE, PhD
Institut de Formation et Recherche Demographique (IFORD)
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2014
First Posted
July 17, 2014
Study Start
November 1, 2014
Primary Completion
December 1, 2015
Study Completion
July 1, 2016
Last Updated
July 12, 2016
Record last verified: 2016-07